MARGARET FORNI: Open Payments
NPI 1194932541 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$751 in 35 payments from 10 companies in 2025. Trend: 2023 $535 · 2024 $827 · 2025 $751
Food & beverage: $751
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $140 |
| Novo Nordisk Inc | 5 | $118 |
| PFIZER INC. | 5 | $106 |
| Philips North America LLC | 5 | $105 |
| Amgen Inc. | 4 | $83 |
| E.R. Squibb & Sons, L.L.C. | 4 | $73 |
| GlaxoSmithKline, LLC. | 3 | $69 |
| BridgeBio Pharma, Inc. | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
Products named: ELIQUIS, FARXIGA, ECC Solutions, REPATHA, SHINGRIX, Wegovy, CAMZYOS, Ozempic.
Industry payments across TN — which companies pay providers there.
